OSIRIS THERAPEUTICS, INC.
Healthcare · Biological Products, (No Diagnostic Substances) · MD · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | |
|---|---|---|---|---|---|---|
| Revenue | $142.8M | $118.5M | — | — | $10.1M | $4.1M |
| Operating income | $9.9M | −$2.0M | −$589,000 | −$9.0M | $1.7M | −$2.8M |
| Net income | $36.9M | $8.8M | −$544,000 | −$8.7M | — | — |
| Total assets | $101.5M | $78.1M | $72.6M | $83.7M | $98.1M | $92.1M |
| Total liabilities | $23.0M | $36.7M | $37.1M | $15.8M | $14.2M | $11.1M |
| Equity | $78.5M | $41.4M | $32.5M | $67.9M | $75.7M | $80.9M |
| EPS (diluted) | $1.07 | $0.25 | $-0.11 | $-1.04 | — | $-0.08 |
| Shares out. | 34.5M | 34.5M | 34.5M | 34.4M | 34.2M | 32.9M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2018- Operating margin
- 6.9%
- Net margin
- 25.8%
- Return on equity
- 47.0%
- Return on assets
- 36.4%
- Return on capital (ROCE)
- 12.2%
- Liabilities / assets
- 22.6%
- Debt / equity
- 0.29×
- Book value / share
- $2.27
- Revenue growth (YoY)
- 20.5%
- Net income growth (YoY)
- 320.0%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2018- Altman Z″ (distress)
- 0.85distress
- Accruals / assets
- 29.2%high accruals
- Beneish M-Score
- 4.06elevated
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 severe● 2 warning● 5 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- High accruals — earnings-quality risk
- Beneish M-Score elevated — earnings-manipulation screen flag
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Kmissed a reporting deadline ↗Mar 16, 2018
- NT 10-Qmissed a reporting deadline ↗Nov 13, 2017
- NT 10-Qmissed a reporting deadline ↗Aug 10, 2017
- NT 10-Qmissed a reporting deadline ↗May 11, 2017
- NT 10-Kmissed a reporting deadline ↗Mar 17, 2017
- NT 10-Qmissed a reporting deadline ↗Nov 14, 2016
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventApr 17, 2019
- Entered a material agreement · Other material eventMar 12, 2019
- Other material eventMar 12, 2019
- Director / officer changeNov 26, 2018
- Other material eventNov 8, 2018
- Results of operationsNov 7, 2018
- Other material eventSep 17, 2018
- Director / officer changeSep 11, 2018
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (3)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.